.::Ironwood Pharmaceuticals::.

Press Releases 2013

Press Releases 2012

Press Releases 2011

Press Releases 2010

Press Releases 2009

Press Releases 2008

Press Releases 2007

Press Releases 2006

Press Releases 2005

Press Releases 2004

Press Releases 2003

11.02.04
Microbia Announces Evidence that MD-1100 has Potential to Alleviate Pain Associated with Irritable Bowel Syndrome
Data to be Presented Today at the 69th American College of Gastroenterology Annual Scientific Meeting

11.01.04
Microbia Announces Initiation of Phase I Clinical Trial for Novel, Oral IBS Treatment

09.20.04
David E. Shaw Joins Microbia Board of Directors
Founder of IDEXX Laboratories, Inc.

05.19.04
Microbia Presents Data on Novel Drug Candidate with Potential to Treat Irritable Bowel Syndrome
Data Presented at Digestive Disease Week Conference

05.04.04
Microbia Raises $40 Million in Series D Financing
Proceeds Will be Used to Advance Portfolio of Therapeutic Candidates

01.13.04
Christopher T. Walsh, Ph.D., Joins Microbia Board of Directors; Walsh, Halushka, & Corey
Named to Newly Formed Pharmaceutical Advisory Committee
Walsh to Chair PAC

Lisa Buffington

VP, Corporate Communications
617.374.5103
lbuffington@ironwoodpharma.com